Please Wait
Applying Filters...
menu
    • menu
    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    lanzoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New REDUCE-IT Analysis Reinforces Benefit Of Icosapent Ethyl
    New REDUCE-IT Analysis Reinforces Benefit Of Icosapent Ethyl

    09 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/09/3184162/18362/en/New-REDUCE-IT-Aspirin-Analysis-Presented-at-AHA-Scientific-Sessions-2025-Reinforces-VASCEPA-VAZKEPA-Icosapent-Ethyl-Reduced-Cardiovascular-Events-in-High-Risk-Patients.html

    GLOBENEWSWIRE
    09 Nov 2025
    Share Share
    Amarin Reports Third Quarter 2025 Financial Results
    Amarin Reports Third Quarter 2025 Financial Results

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176292/18362/en/Amarin-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Amarin Supports FDA Labeling Revision On Fenofibrate, Affirming
    Amarin Supports FDA Labeling Revision On Fenofibrate, Affirming

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174541/18362/en/Amarin-Issues-Statement-Supporting-FDA-s-Action-to-Revise-Labeling-for-Fenofibrate-Drugs-Reinforcing-a-Lack-of-Cardiovascular-Benefit.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Amarin To Present Q3 2025 Financials, Conduct Conference Call
    Amarin To Present Q3 2025 Financials, Conduct Conference Call

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3167038/18362/en/Amarin-to-Report-Third-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-October-29-2025.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    Amarin, HLS Present REDUCE-IT & EPA Mechanistic Data at Congress
    Amarin, HLS Present REDUCE-IT & EPA Mechanistic Data at Congress

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166085/18362/en/Amarin-and-HLS-Therapeutics-Collaborate-on-Presenting-REDUCE-IT-and-EPA-Mechanistic-Data-at-the-Canadian-Cardiovascular-Congress.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Amarin Showcases Mechanistic Insights on EPA at ESC 2025
    Amarin Showcases Mechanistic Insights on EPA at ESC 2025

    31 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/31/3141915/18362/en/Amarin-Highlights-Key-Data-Providing-Mechanistic-Insights-into-Eicosapentaenoic-Acid-EPA-at-ESC-2025.html

    GLOBENEWSWIRE
    31 Aug 2025
    Share Share